scispace - formally typeset
E

Eduard Monsó

Researcher at Carlos III Health Institute

Publications -  164
Citations -  6908

Eduard Monsó is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: COPD & Exacerbation. The author has an hindex of 36, co-authored 159 publications receiving 6275 citations. Previous affiliations of Eduard Monsó include Autonomous University of Barcelona.

Papers
More filters
Journal ArticleDOI

Bacterial infection in chronic obstructive pulmonary disease : a study of stable and exacerbated outpatients using the protected specimen brush

TL;DR: The lower airways of asymptomatic chronic obstructive pulmonary disease (COPD) patients can be colonized by bacteria, mainly Haemophilus influenza, Streptococcus pneumoniae, and Moraxella catarrhalis, but the role of lower airway bacteria in stable and exacerbated COPD has not been well defined.
Journal ArticleDOI

Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease

TL;DR: HRQL measures provide independent and relevant information on the health status of male patients with COPD and should be considered for a more thorough evaluation and staging of patients with chronic obstructive pulmonary disease.
Journal ArticleDOI

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example

TL;DR: The adaptation into Spanish of the St George's Respiratory Questionnaire (SGRQ), a self-administered questionnaire developed by Jones et al. (1991) covering three domains of health in airways disease patients, suggests that the SGRQ may already be used in Spain and in international studies involving Spanish respiratory patients.
Journal ArticleDOI

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

TL;DR: In patients with COPD recruited at their first hospitalisation, three different COPD subtypes were identified and prospectively validated: ‘severe respiratory COPD’, ‘moderate respiratory COPd’ and ‘systemic COPD'.
Journal ArticleDOI

Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.

TL;DR: Exacerbation is associated with the overgrowth of PPMs and with the appearance of P aeruginosa in the lower airway, which isassociated with exacerbation symptoms independent of load.